Related Experiment Video
Updated: Aug 4, 2026

09:09
A Method for Targeted 16S Sequencing of Human Milk Samples
Published on: March 23, 2018
Genotoxicity of human breast milk from different countries
F L Martin1, K J Cole, G Weaver
1Institute of Cancer Research, Haddow Laboratories, Cotswold Road, Sutton, Surrey SM2 5NG, UK.
Mutagenesis
|August 17, 2001
Summary
Genotoxic agents were found more frequently in UK breast milk than in samples from Hong Kong, India, and Singapore. This suggests a potential link between breast milk DNA damage and breast cancer incidence variations.
Area of Science:
- Environmental Health
- Molecular Toxicology
- Cancer Epidemiology
Background:
- International variations in breast cancer incidence are linked to dietary and environmental factors.
- Breast milk genotoxicity is being investigated as a biomarker for mammary epithelial cell exposure to DNA-damaging agents.
Purpose of the Study:
- To assess the genotoxicity of breast milk extracts from the UK (high breast cancer risk) and Hong Kong, India, and Singapore (lower risk).
- To determine if genotoxic components in breast milk correlate with breast cancer incidence rates.
Main Methods:
- Breast milk samples were collected from the UK (n=32), Hong Kong (n=10), India (n=20), and Singapore (n=20).
- Genotoxicity was evaluated using the alkaline Comet assay for single-strand breaks (SSBs), a micronucleus assay in MCL-5 cells, and bacterial mutagenicity tests in Salmonella typhimurium YG1019.
Main Results:
- UK breast milk samples showed significantly higher induction of DNA SSBs (56%) compared to samples from Hong Kong (20%), India (25%), and Singapore (40%).
- The micronucleus assay revealed significant genotoxic activity in 28% of UK samples, versus 0-15% in other countries.
- Bacterial mutagenicity tests indicated significant activity in 28% of UK samples, with a dose-response effect observed.
Conclusions:
- Genotoxic components appear more prevalent in UK breast milk compared to milk from lower breast cancer incidence countries.
- These findings suggest a potential association between breast milk genotoxicity and geographical variations in breast cancer risk.
- Further research is needed to confirm these results and elucidate their relevance to breast cancer incidence.
More Related Videos
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...

